Tag: ReViral

  • Shares of Pfizer Just Got a Substantial Boost

    Shares of Pfizer Just Got a Substantial Boost

    There goes Pfizer (PFE). The stock is popping on news it’s buying ReViral – a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel antiviral therapeutics that target respiratory syncytial virus (RSV) for $525 million. “Currently, treatment options for RSV are extremely limited and focus primarily on supportive care,” said Annaliesa Anderson,…